Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,952 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07250750RecruitingPhase 1/Phase 2
IM-101 for generalized and ocular myasthenia gravis
This study tests a new medicine called IM-101 in people with myasthenia gravis (MG), a muscle weakness condition. It aims to see if it can safely help manage symptoms.
Altamonte Springs, FloridaAges 18–74 - NCT07251023RecruitingPhase 3
Testing a new drug for Alzheimer's dementia
This study tests whether a new drug called Latrepirdine (DMB-I) is safe and effective for people with mild to moderate Alzheimer's dementia. It may help slow cognitive decline when added to current treatment or used alone.
Kazan'Ages 60–90 - NCT07617597RecruitingPhase 3
Testing deuruxolitinib for severe hair loss in Japanese adults
This study tests whether a new drug called deuruxolitinib can help regrow hair in people with alopecia areata (an autoimmune condition causing patchy hair loss). The drug works by blocking certain immune signals that attack hair follicles.
AsahikawaAges 18–65 - NCT07037459RecruitingPhase 3
A study of a new drug for heart failure with obesity
This trial tests a medication called maridebart cafraglutide for people with heart failure (where the heart doesn't pump as well as it should) and obesity. The goal is to see if it can help improve symptoms and outcomes.
Birmingham, AlabamaAges 18–99 - NCT07682233RecruitingPhase 2
Study on a mitochondrial target and blood sugar control
This study tests a medicine called XBD173 to see how it affects blood sugar by targeting a protein inside cells' mitochondria. It may help people without diabetes learn about new ways to regulate blood sugar.
LondonAges 18–75 - NCT07389044RecruitingPhase 1
Safety study of IB-001 injection in healthy people and hepatitis B patients
This study tests a new injection called IB-001 in two groups: healthy people and people with chronic hepatitis B. The goal is to see if it's safe and how the body handles it at different doses. It might offer a new treatment option for hepatitis B in the future.
ChisinauAges 18–70 - NCT07405554RecruitingPhase 2
Zinc with botox for overactive bladder
This trial tests whether taking zinc along with a botox injection (a standard treatment) can better reduce sudden, strong urges to urinate in women with overactive bladder who haven't gotten relief from other treatments.
Skokie, IllinoisAges 21–100 - NCT07362992RecruitingEarly Phase 1
Tranexamic acid gel to reduce bleeding during cesarean
This study tests whether applying a medicine called tranexamic acid directly to the uterus during a scheduled cesarean can reduce bleeding. It may help women who are having their first or second cesarean delivery.
Holon, Central DistrictAges 18–51 - NCT07251244Recruiting
Supplement and exercise for immune health in older adults
This trial tests whether a combination of a supplement and moderate exercise can help keep your immune system strong and healthy as you age. It is for older adults who are independent and generally healthy.
Valencia, ValenciaAges 65 years+ - NCT07251309RecruitingPhase 3
Study of WS016 for treating high potassium levels
This trial tests a new drug called WS016 to lower high potassium levels in adults. High potassium can be dangerous for your heart, and this study aims to find out if WS016 is safe and effective.
Bengbu, AnhuiAges 18 years+ - NCT07252492Recruiting
Testing a new hearing device for people with hearing loss
This study tests a new hearing device called 'Audiocap' to see if it helps people with mild to moderate hearing loss hear better. It may be an option if you are getting your first hearing aid.
Lyon, FranceAges 18 years+ - NCT07252778RecruitingPhase 2/Phase 3
Probiotics for endurance athletes
This trial tests if taking a probiotic supplement for a short time can help athletes who do endurance sports like rowing. If you are a healthy athlete on a national team, this study might help you understand how probiotics affect performance.
Poznan, WielkopolskaAges 16–50 - NCT07254481RecruitingPhase 1
Safety study of VB19055 in healthy volunteers
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
HangzhouAges 18–50 - NCT07254429RecruitingPhase 2
The Copenhagen Menopause Study for hot flash relief
This study tests a new treatment for women going through menopause who have frequent hot flashes. It aims to find a safe and effective way to reduce moderate to severe hot flashes.
HerlevAges 40–65 - NCT07257029RecruitingPhase 2
Ketotifen Cream for Vulvar Pain
This trial tests a topical cream called ketotifen for treating a type of vulvar pain (secondary provoked vestibulodynia). The cream may help reduce pain at the vaginal opening, and you would apply it daily for several months.
Washington D.C., District of ColumbiaAges 18 years+ - NCT07257198RecruitingPhase 3
Aspirin-free care with ticagrelor after a heart attack treated without stents or bypass
This trial tests whether taking ticagrelor (a blood thinner) alone, without aspirin, is safe and effective for people who have had a heart attack and are being treated with medication only (no stents or bypass surgery). It could mean fewer pills and possibly reduce bleeding risks.
Montreal, QuebecAges 18 years+ - NCT07258160RecruitingPhase 2
Cordycepin for low CD8+ cells in solid tumor patients
This trial tests a supplement derived from cordyceps mushrooms to see if it can raise low CD8+ immune cell levels in people who have had solid tumors. It may help strengthen your immune system after previous cancer treatments.
Suzhou, JiangsuAges 18 years+ - NCT07258849RecruitingPhase 1
Study of LY4213663 in healthy people and rheumatoid arthritis
This study tests a new medicine called LY4213663 in healthy volunteers and people with rheumatoid arthritis. It aims to see if the medicine is safe and how the body handles it.
Anniston, AlabamaAges 18–75 - NCT07259252Recruiting
Flu vaccine study for heart attack or unstable angina patients
This study tests whether getting a flu vaccine helps people who recently had a heart attack or unstable angina (acute coronary syndrome). It looks at whether vaccination can reduce future heart problems.
Wuhan, HubeiAges 18–80 - NCT07260669RecruitingPhase 2
Vipoglanstat for endometriosis-related pelvic pain
This study tests an investigational drug called Vipoglanstat for women with endometriosis-related pelvic pain that happens even when they are not on their period. The goal is to see if it can reduce pain and improve quality of life.
BlagoevgradAges 18–44 - NCT07260656RecruitingEarly Phase 1
Capsaicin cream for diabetic nerve foot pain
This trial tests a new cream (Capsadyn®) made from chili pepper extract to see if it can reduce nerve pain in the feet caused by diabetes. If it works, it could offer a simple treatment you apply at home.
Roanoke, VirginiaAges 25–75 - NCT07261644RecruitingPhase 3
Study of a new drug for active ankylosing spondylitis
This study tests a new medication (called 608) for adults with active ankylosing spondylitis (AS). It aims to see if the drug can reduce AS symptoms and improve quality of life.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07262060RecruitingPhase 2
Preventing kidney problems in preterm babies with caffeine
This study tests whether giving caffeine to very premature babies can help protect their kidneys as they grow. We will use a special light monitor on the skin to check blood flow to the brain and kidneys.
Madison, WisconsinAges 12 hours–4 days - NCT07263217Recruiting
Spirulina for liver protection after bile duct cancer surgery
This trial tests whether spirulina (a type of algae) can help protect the liver and aid recovery after surgery for bile duct cancer. Participants will take spirulina or a placebo before and after a planned liver resection.
HangzhouAges 18–75
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,952 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.